Annovis Bio Achieves NYSE Listing Compliance
Annovis Bio has successfully met the New York Stock Exchange's listing requirements, thereby preventing a potential delisting. This achievement occurred before the expiration of its 18-month cure period. The company's compliance is expected to offer increased stability for both the firm and its investors.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.